{"version":"1.0","type":"link","title":"Mutation-based, short-term \"neoadjuvant\" treatment allows resectability in stage IVB and C anaplastic thyroid cancer.","author_name":"Maurer E 외","author_url":"https://prs-insight.online/author/Maurer%20E","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/146299","thumbnail_width":1200,"thumbnail_height":630}